CRSP Q2 EPS Estimate Reduced by Brookline Capital Management
CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) – Analysts at Brookline Capital Management cut their Q2 2025 earnings estimates for shares of CRISPR Therapeutics in a research report issued on Tuesday, May 6th. Brookline Capital Management analyst L. Cann now expects that the company will post earnings of ($1.23) per share for the quarter, down […]
More Stories
Mutual of America Capital Management LLC Trims Stock Holdings in Arbor Realty Trust (NYSE:ABR)
Mutual of America Capital Management LLC lessened its holdings in shares of Arbor Realty Trust (NYSE:ABR – Free Report) by...
Provident Financial Services, Inc (NYSE:PFS) Shares Sold by Mutual of America Capital Management LLC
Mutual of America Capital Management LLC trimmed its position in shares of Provident Financial Services, Inc (NYSE:PFS – Free Report)...
Mutual of America Capital Management LLC Has $294,000 Stock Holdings in The Chemours Company (NYSE:CC)
Mutual of America Capital Management LLC trimmed its position in The Chemours Company (NYSE:CC – Free Report) by 72.4% in...
Mutual of America Capital Management LLC Sells 706 Shares of CoreCivic, Inc. (NYSE:CXW)
Mutual of America Capital Management LLC cut its holdings in shares of CoreCivic, Inc. (NYSE:CXW – Free Report) by 4.2%...
Mutual of America Capital Management LLC Sells 184 Shares of Albany International Corporation (NYSE:AIN)
Mutual of America Capital Management LLC reduced its position in shares of Albany International Corporation (NYSE:AIN – Free Report) by...
Mutual of America Capital Management LLC Trims Position in Tidewater Inc. (NYSE:TDW)
Mutual of America Capital Management LLC trimmed its position in shares of Tidewater Inc. (NYSE:TDW – Free Report) by 3.9%...